Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors
X Wang, T Furukawa, T Nitanda, M Okamoto… - Molecular …, 2003 - ASPET
Breast cancer resistance protein (BCRP/ABCG2) is a novel member of ATP-binding cassette
transporters, which induce multidrug resistance in cancer cells. We found that a high level of …
transporters, which induce multidrug resistance in cancer cells. We found that a high level of …
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes
Different mechanisms of drug resistance, including ATP-binding cassette (ABC) transporters,
are responsible for treatment failure of tumors. We developed a low-density DNA microarray …
are responsible for treatment failure of tumors. We developed a low-density DNA microarray …
[HTML][HTML] The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer
M Pasello, AM Giudice, K Scotlandi - Seminars in cancer biology, 2020 - Elsevier
Overexpression of ATP-binding cassette (ABC) transporters is a cause of drug resistance in
a plethora of tumors. More recent evidence indicates additional contribution of these …
a plethora of tumors. More recent evidence indicates additional contribution of these …
[HTML][HTML] ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance
Multidrug resistance (MDR) is the phenomenon in which cancer cells simultaneously
develop resistance to a broad spectrum of structurally and mechanistically unrelated drugs …
develop resistance to a broad spectrum of structurally and mechanistically unrelated drugs …
Phytochemicals: potential lead molecules for MDR reversal
Multidrug resistance (MDR) is one of the main impediments in the treatment of cancers.
MDR cancer cells are resistant to multiple anticancer drugs. One of the major mechanisms of …
MDR cancer cells are resistant to multiple anticancer drugs. One of the major mechanisms of …
[HTML][HTML] Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance
Drug metabolism is an orchestrated process in which drugs are metabolized and disposed
through a series of specialized enzymes and transporters. Alterations in the expression …
through a series of specialized enzymes and transporters. Alterations in the expression …
Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328,-519c and-520h) and their differential expression in stem-like ABCG2+ cancer …
Recent studies have shown that a number of microRNAs (miRNA or miR) may regulate
human breast cancer resistance protein (BCRP/ABCG2), an important efflux transporter …
human breast cancer resistance protein (BCRP/ABCG2), an important efflux transporter …
[HTML][HTML] Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated …
The development of drug resistance continues to be a dominant hindrance toward curative
cancer treatment. Overexpression of a wide-spectrum of ATP-dependent efflux pumps, and …
cancer treatment. Overexpression of a wide-spectrum of ATP-dependent efflux pumps, and …
Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters
ZX He, TQ Zhao, YP Gong, X Zhang, LY Ma… - European Journal of …, 2020 - Elsevier
The multidrug resistance (MDR) phenomenon in cancer cells is the major obstacle leading
to failure of chemotherapy accompanied by the feature of intractable and recurrence of …
to failure of chemotherapy accompanied by the feature of intractable and recurrence of …
The role of ABC transporters in progression and clinical outcome of colorectal cancer
I Hlavata, B Mohelnikova-Duchonova… - …, 2012 - academic.oup.com
Worldwide, colorectal cancer (CRC) is the third most common cancer, with the highest
mortality rates occurring in Central Europe. The use of chemotherapy to treat CRC is limited …
mortality rates occurring in Central Europe. The use of chemotherapy to treat CRC is limited …